Silence Therapeutics PLC (SLNCF) — 10-Q Filings
All 10-Q filings from Silence Therapeutics PLC. Browse 3 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (3)
-
Silence Therapeutics' Losses Widen Amid R&D Surge, Revenue Plunge
— Nov 6, 2025 Risk: high
Silence Therapeutics plc reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $76.8 million, up from $57.6 million -
Silence Therapeutics' Q2 Loss Widens Amid Declining Collaboration Revenue
— Aug 7, 2025 Risk: high
Silence Therapeutics plc reported a net loss of $15.2 million for the three months ended June 30, 2025, compared to a net loss of $13.5 million for the same per -
Silence Therapeutics Q1 2025 Update
— May 8, 2025 Risk: medium
Silence Therapeutics plc filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates. Key financial da
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX